| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 901 | 2022 |
| Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 J Huo, A Le Bas, RR Ruza, HME Duyvesteyn, H Mikolajek, T Malinauskas, ... Nature structural & molecular biology 27 (9), 846-854, 2020 | 477 | 2020 |
| Neutralization of SARS-CoV-2 by destruction of the prefusion spike J Huo, Y Zhao, J Ren, D Zhou, HME Duyvesteyn, HM Ginn, L Carrique, ... Cell host & microbe 28 (3), 445-454. e6, 2020 | 365 | 2020 |
| The antigenic anatomy of SARS-CoV-2 receptor binding domain W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn, P Supasa, JB Case, ... Cell 184 (8), 2183-2200. e22, 2021 | 352 | 2021 |
| Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient D Zhou, HME Duyvesteyn, CP Chen, CG Huang, TH Chen, SR Shih, ... Nature structural & molecular biology 27 (10), 950-958, 2020 | 286 | 2020 |
| A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses TK Tan, P Rijal, R Rahikainen, AH Keeble, L Schimanski, S Hussain, ... Nature communications 12 (1), 542, 2021 | 229 | 2021 |
| Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern DT Skelly, AC Harding, J Gilbert-Jaramillo, ML Knight, S Longet, A Brown, ... Nature communications 12 (1), 5061, 2021 | 154 | 2021 |
| An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease Y Peng, SL Felce, D Dong, F Penkava, AJ Mentzer, X Yao, G Liu, Z Yin, ... Nature immunology 23 (1), 50-61, 2022 | 138 | 2022 |
| Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models AA Cohen, N van Doremalen, AJ Greaney, H Andersen, A Sharma, ... Science 377 (6606), eabq0839, 2022 | 129 | 2022 |
| Hepcidin-mediated hypoferremia disrupts immune responses to vaccination and infection JN Frost, TK Tan, M Abbas, SK Wideman, M Bonadonna, NU Stoffel, ... Med 2 (2), 164-179. e12, 2021 | 74 | 2021 |
| Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses Q Tang, RE Rigby, GR Young, AK Hvidt, T Davis, TK Tan, A Bridgeman, ... Immunity 54 (9), 1961-1975. e5, 2021 | 72 | 2021 |
| Breadth and function of antibody response to acute SARS-CoV-2 infection in humans KYA Huang, TK Tan, TH Chen, CG Huang, R Harvey, S Hussain, ... Plos pathogens 17 (2), e1009352, 2021 | 70 | 2021 |
| A haemagglutination test for rapid detection of antibodies to SARS-CoV-2 A Townsend, P Rijal, J Xiao, TK Tan, KYA Huang, L Schimanski, J Huo, ... Nature communications 12 (1), 1951, 2021 | 62 | 2021 |
| Overcoming symmetry mismatch in vaccine nanoassembly through spontaneous amidation R Rahikainen, P Rijal, TK Tan, HJ Wu, AMC Andersson, JR Barrett, ... Angewandte Chemie International Edition 60 (1), 321-330, 2021 | 59 | 2021 |
| Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sites AJ MacLean, N Richmond, L Koneva, M Attar, CAP Medina, EE Thornton, ... Immunity 55 (4), 718-733. e8, 2022 | 56 | 2022 |
| Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern. DT Skelly, AC Harding, J Gilbert-Jaramillo, ML Knight, S Longet, A Brown, ... | 52 | 2021 |
| Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers C Jeewandara, A Kamaladasa, PD Pushpakumara, D Jayathilaka, ... Nature Communications 12 (1), 4617, 2021 | 39 | 2021 |
| The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells X Zhuang, S Tsukuda, F Wrensch, PAC Wing, M Schilling, JM Harris, ... IScience 24 (10), 2021 | 38 | 2021 |
| Broadly inhibiting antineuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans P Rijal, BB Wang, TK Tan, L Schimanski, P Janesch, T Dong, ... Journal of virology 94 (4), 10.1128/jvi. 01182-19, 2020 | 31 | 2020 |
| Antibody and T cell responses to Sinopharm/BBIBP-CorV in naïve and previously infected individuals in Sri Lanka C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ... MedRxiv, 2021.07. 15.21260621, 2021 | 30 | 2021 |
Alain TownsendProfessor of Molecular Immunology, Oxford UniversityDirección de correo verificada de imm.ox.ac.uk
